Clinical outcomes following a trial of sertraline in rheumatoid arthritis

Psychosomatics
James R SlaughterJames E Hewett

Abstract

We report an open-label trial of sertraline in the treatment of major depression in 54 consecutive rheumatoid arthritis (RA) patients meeting DSM-IV criteria for major depressive disorder. We initially surveyed 628 RA outpatients with the Center for Epidemiologic Studies Depression Scale (CES-D) and invited those with depression to be evaluated further and treated. Eighty-four RA patients reporting depressive symptoms agreed to participate in person, and 56 met the criteria for major depressive disorder. Of these 56 patients, 54 agreed to medication treatment and were enrolled in the study. Patients were also randomized to one of three psychological treatment conditions, but for this study, conditions were collapsed because previous research on this sample indicated no significant between-group differences in depression after treatment. Patients were assessed with the CES-D and the Hamilton Rating Scale for Depression after the intervention, at 6-month follow-up, and at 15-month follow-up. At the last follow-up, 41 patients remained for assessment. In this study, sertraline was found to be a safe and efficacious treatment of depression complicating RA.

References

Jan 1, 1990·Journal of Psychosomatic Research·F CreedM V Jayson
May 1, 1988·Arthritis and Rheumatism·J C ParkerS E Walker
Nov 1, 1989·Journal of General Internal Medicine·J L CoulehanM R Block
Oct 1, 1988·British Journal of Rheumatology·S MurphyM I Jayson
Sep 1, 1972·Archives of General Psychiatry·J G WilliamsW S Agras
Jan 1, 1994·Behaviour Research and Therapy·D C Turk, A Okifuji
Sep 1, 1996·British Journal of Rheumatology·T PincusD Isenberg
Dec 1, 1995·Arthritis and Rheumatism·J C ParkerS E Walker
Aug 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·G E WrightJ E Hewett
Mar 4, 1998·Arthritis and Rheumatism·G E WrightS E Walker
Mar 20, 1999·Rheumatic Diseases Clinics of North America·B A Huyser, J C Parker
Apr 17, 1999·The Clinical Journal of Pain·E LeibingG Schuessler
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Jan 2, 2004·The Nurse Practitioner·Doris AlexanderCharles Zeilman
Jul 17, 2012·Neuroimmunomodulation·Ehud BaharavAvraham Weizman
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Bethan L RichardsRachelle Buchbinder
Dec 29, 2020·Frontiers in Medicine·Francesca IngegnoliRoberto Caporali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.